The insights gained from the proteomic complexity of p53 and its interactions with ncRNAs provide valuable directions for future therapeutic strategies aimed at reactivating p53-mediated tumor suppression while overcoming drug resistance. This evidence concerns the gene TP53 and neoplasm.